for people ages 18 years and up (full criteria)
at San Francisco, California
study started
completion around
Principal Investigator
by Janice Tsoh, PhD
Headshot of Janice Tsoh
Janice Tsoh



This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.

Official Title

Connect Cancer Patients to Tobacco Cessation Care by Automated Interactive Outreach



  1. To evaluate CareConnect's efficacy on referring patients to tobacco cessation resources.


  1. To evaluate patients' acceptance of referrals.

II. To evaluate the acceptability of CareConnect.


  1. In-depth semi-structured qualitative interviews of 20 randomly selected participants who completed the 3-month follow-up call (10 from each group).

II. Smoking cessation with verification.


Eligible participants, identified through the Cancer Center Tobacco Registry will be randomized to either the Intervention or Control arm on a 1:1 ratio. Participants who complete the first call of CareConnect or AutoReach will be considered enrolled. Participants will complete a baseline assessment, a 3-month assessment, and have option to provide a saliva sample.

For those who are selected to participate in an in-depth interview, this will take place within 1 month after the 3-month assessment. Data from the participants medical record may be accessed at 6 months post follow-up.


Cancer, Tobacco Dependence, Tobacco Use Cessation, Interactive Intervention, Tobacco Use Disorder, CareConnect, AutoReach


You can join if…

Open to people ages 18 years and up

  1. Age 18 years and older.
  2. Able to understand study procedures and to comply with them for the entire length of the study.
  3. Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
  4. English, Spanish, Cantonese, or Mandarin speaking.
  5. Self-reported current use of tobacco, including e-cigarette on EHR.
  6. Has a diagnosis of cancer.
  7. Has been seen by a prescribing provider within a UCSF Cancer Center-affiliated clinical department within the past 3 months.

You CAN'T join if...

  1. Contraindication to any study-related procedure or assessment.
  2. No valid contact telephone number.
  3. Currently hospitalized or having been discharged from inpatient setting within the past month (according to EHR).


  • UCSF accepting new patients
    San Francisco California 94143 United States

Lead Scientist at UCSF

  • Janice Tsoh, PhD
    I am a practicing clinical psychologist and Professor of Psychiatry and Behavioral Sciences at the University of California San Francisco (UCSF). I also serve as Co-Director of the Asian American Research Center on Health (


accepting new patients
Start Date
Completion Date
University of California, San Francisco
Study Type
Expecting 400 study participants
Last Updated